Tackling the Disproportionate Burden of Resistant Hypertension in US Black Adults

Charchar FJ, Prestes PR, Mills C, Ching SM, Neupane D, Marques FZ, et al. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J Hypertens. 2024;42(1):23–49. https://doi.org/10.1097/HJH.0000000000003563.

Article  CAS  PubMed  Google Scholar 

Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–71. https://doi.org/10.1016/j.jacc.2022.11.005.

Article  PubMed  Google Scholar 

Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et a. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 Heart Disease and Stroke Statistics: A report of US and global data from the American Heart Association. Circulation. 2024;149(8):e347-e913.

Kazi DS, Elkind MSV, Deutsch A, Dowd WN, Heidenreich P, Khavjou O, et al. Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: a presidential advisory from the American Heart Association. Circulation. 2024. https://doi.org/10.1161/CIR.0000000000001258.

Article  PubMed  Google Scholar 

Centers for Disease Control and Prevention and National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES) public use data files. https://cdc.gov/nchs/nhanes/ Accessed May 23, 2024.

Bress AP, Anderson TS, Flack JM, Ghazi L, Hall ME, Laffer CL, et al.; American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. The management of elevated blood pressure in the acute care setting: a scientific statement from the American Heart Association. Hypertension. 2024. https://doi.org/10.1161/HYP.0000000000000238.

Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med. 2021;385:1268–79. https://doi.org/10.1056/NEJMoa2111437.

Article  CAS  PubMed  Google Scholar 

SPRINT Research Group. Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, et al. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med 2021;384:1921–1930. https://doi.org/10.1056/NEJMoa1901281.

Vaduganathan M, Claggett BL, Juraschek SP, Solomon SD. Assessment of long-term benefit of intensive blood pressure control on residual life span: secondary analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Cardiol. 2020;5:576–81. https://doi.org/10.1001/jamacardio.2019.6192.

Article  PubMed  Google Scholar 

KFF Life Expectancy health system tracker. https://www.healthsystemtracker.org/indicator/health-well-being/life-expectancy. Accessed May 23, 2024.

Jain V, Minhas AMK, Morris AA, Greene SJ, Pandey A, Khan SS, et al. Demographic and regional trends of heart failure-related mortality in young adults in the US, 1999–2019. JAMA Cardiol. 2022;7(9):900–4. https://doi.org/10.1001/jamacardio.2022.2213.

Article  PubMed  PubMed Central  Google Scholar 

Hung AM, Assimon VA, Chen H-C, et al. Genetic inhibition of APOL1 pore-forming function prevents APOL1-mediated kidney disease. J Am Soc Nephrol. 2023;34(11):1889–99. https://doi.org/10.1681/asn.0000000000000219.

Article  PubMed  Google Scholar 

United States Renal Data System (USRDS) Annual Data Report. https://adr.usrds.org/2021/end-stage-renal-disease/1-incidence-prevalence-patient-characteristics-and-treatment-modalities​. Accessed: May 23, 2024

Zakai NA, Minnier J, Safford MM, Koh I, Irvin MR, Fazio S, et al. Race-dependent association of high-density lipoprotein cholesterol levels with incident coronary artery disease. J Am Coll Cardiol. 2022;80(22):2104–15. https://doi.org/10.1016/j.jacc.2022.09.027.

Article  CAS  PubMed  Google Scholar 

Brandt EJ, Tobb K, Cambron JC, Ferdinand K, Douglass P, Nguyen PK, et al. Assessing and addressing social determinants of cardiovascular health: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81(14):1368–85.

Article  PubMed  PubMed Central  Google Scholar 

Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, et al.; American Heart Association. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation 2023;148(24):1982–2004. https://doi.org/10.1161/CIR.0000000000001191.

Collaboration BPLTT. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625–36. https://doi.org/10.1016/S0140-6736(21)00590-0.

Article  Google Scholar 

Jaeger BC, Bress AP, Bundy JD. Longer-term all-cause and cardiovascular mortality with intensive blood pressure control: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2022;7(11):1138–46. https://doi.org/10.1001/jamacardio.2022.3345.

Article  PubMed  PubMed Central  Google Scholar 

Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al;. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269–1324. https://doi.org/10.1161/HYP.0000000000000080.

Derington CG, Bress AP, Herrick JS, Jacobs JA, Zheutlin AR, Berchie RO, et al. Antihypertensive medication regimens used by US Adults with hypertension and the potential for fixed-dose combination products: The National Health and Nutrition Examination Surveys 2015 to 2020. J Am Heart Assoc. 2023;12(11):e028573. https://doi.org/10.1161/HYPERTENSIONAHA.119.14360.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flack JM, Buhnerkempe MG, Moore KT. Resistant hypertension: disease burden and emerging treatment options. Curr Hypertens Rep. 2024. https://doi.org/10.1007/s11906-023-01282-0.

Article  PubMed  Google Scholar 

Joseph JJ, Nolan TS, Williams A, McKoy A, Zhao S, Aboagye-Mensah E, et al. Improving cardiovascular health in black men through a 24-week community-based team lifestyle change intervention: the black impact pilot study. Am J Prev Cardiol. 2022;9:100315. https://doi.org/10.1016/j.ajpc.2022.100315.

Article  PubMed  PubMed Central  Google Scholar 

Ferdinand KC. The case for eliminating racial and ethnic cardiovascular disparities in the USA. Nat Rev Cardiol. 2024;21(2):65–6. https://doi.org/10.1038/s41569-023-00971-2.

Article  PubMed  Google Scholar 

Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al.; American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Genomic and Precision Medicine; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72(5):e53-e90. https://doi.org/10.1161/HYP.0000000000000084.

Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. J Hypertens. 2018;36(10):1953–2041. https://doi.org/10.1097/hjh.0000000000001940.

Article  CAS  PubMed  Google Scholar 

Langford AT, Akinyelure OP, Moore TL Jr, Howard G, Min YI, Hillegass WB, et al. Underutilization of treatment for Black adults with apparent treatment-resistant hypertension: JHS and the REGARDS study. Hypertension. 2020;76(5):1600–7. https://doi.org/10.1161/HYPERTENSIONAHA.120.14836.

Article  CAS  PubMed  Google Scholar 

Ferdinand KC. The Healthy Heart Community Prevention Project: a model for primary cardiovascular risk reduction in the African-American population. J Natl Med Assoc. 1995;87(8 Suppl):638–41. PMID: 7674364; PMCID: PMC2607934.

Victor RG, Lynch K, Li N, Blyler C, Muhammad E, Handler J, et al. A cluster-randomized trial of blood-pressure reduction in Black barbershops. N Engl J Med. 2018;378(14):1291–301. https://doi.org/10.1056/NEJMoa1717250.

Article  PubMed  PubMed Central  Google Scholar 

Ferdinand KC, Charbonnet RM, Laurent J, Villavaso CD. Eliminating hypertension disparities in U.S. non-Hispanic black adults: current and emerging interventions. Curr Opin Cardiol. 2023;38(4):304–310. https://doi.org/10.1097/HCO.0000000000001040.

Ferdinand DP, Reddy TK, Wegener MR, Guduri PS, Lefante JJ, Nedunchezhian S, et al. TEXT MY BP MEDS NOLA: A pilot study of text-messaging and social support to increase hypertension medication adherence. Am Heart J Plus. 2023;26:100253. https://doi.org/10.1016/j.ahjo.2023.100253.

Article  PubMed  PubMed Central  Google Scholar 

Katz ME, Mszar R, Grimshaw AA, Gunderson CG, Onuma OK, Lu Y, et al. Digital health interventions for hypertension management in US populations experiencing health disparities: a systematic review and meta-analysis. JAMA Netw Open. 2024;7(2):e2356070. https://doi.org/10.1001/jamanetworkopen.2023.56070.

Article  PubMed  PubMed Central  Google Scholar 

Maroney K, Laurent J, Alvarado F, Gabor A, Bell C, Ferdinand K, et al. Systematic review and meta-analysis of church-based interventions to improve cardiovascular disease risk factors. Am J Med Sci. 2023;366(3):199–208. https://doi.org/10.1016/j.amjms.2023.05.010.

Article  PubMed  Google Scholar 

Tulane University Translational Science Institute. Website: https://tulanectsi.org/cherish/ Accessed: May 30, 2024

Abdalla M, Bolen SD, Brettler J, Egan BM, Ferdinand KC, Ford CD, et al. American Heart Association and American Medical Association. Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American Heart Association and American Medical Association. Hypertension. 2023;80(10):e143-e157. https://doi.org/10.1161/HYP.0000000000000232.

Martínez-Ibáñez P, Marco-Moreno I, García-Sempere A, Peiró S, Martínez-Ibáñez L, Barreira-Franch I, et al.; ADAMPA Research Group. Long-term effect of home blood pressure self-monitoring plus medication self-titration for patients with hypertension: a secondary analysis of the ADAMPA randomized clinical trial. JAMA Netw Open. 2024;7(5):e2410063. https://doi.org/10.1001/jamanetworkopen.2024.10063.

Ferdinand KC. Novel interventions in addressing racial disparities in blood pressure control: potential utilization of barbershops in Black men. Circulation. 2018;138(4):339–41. https://doi.org/10.1161/CIRCULATIONAHA.118.034869.

Article  PubMed  Google Scholar 

Jafari E, Cooper-DeHoff RM, Effron MB, Hogan WR, McDonough CW. Characteristics and predictors of apparent treatment-resistant hypertension in real-world populations using electronic health record-based data. Am J Hypertens. 2024;37(1):60–8. https://doi.org/10.1093/ajh/hpad084.

Article  PubMed  Google Scholar 

Ma X, McKie PM, Iyer SR, Scott C, Bailey K, Johnson BK, et al. MANP in hypertension with metabolic syndrome: proof-of-concept study of natriuretic peptide-based therapy for cardiometabolic disease. J Am Coll Cardiol Basic Trans Science. 2024;9(1):8–29. https://doi.org/10.1016/j.jacbts.2023.08.011.

留言 (0)

沒有登入
gif